Traditional reinsurance underwriting often relied on annual renewal cycles, limited historical datasets, and delayed loss ...

That said, Recursion doesn't have a single therapy on the market yet. Over the past four years, the company has made little ...

Recent breakthroughs in artificial intelligence have transformed protein structure biology from a data-limited discipline into a data-driven frontier of ...

Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...

Our approach is based on the observation that structure-update statements manipulate recursive data structures in a slice-and-splice way: the original data structures are sliced into several disjoint ...

Abstract Linear type systems permit programmers to deallocate or explicitly recycle memory, but they are severly restricted by the fact that they admit no aliasing. This paper describes a ...

Recursion is a powerful technique used to solve problems with repeating patterns, and is a fundamental structure in software. To date there is no known general way to apply a recursive solution to ...

Recursion strengthened its tech stack through partnerships and collaborations with big players. Read why I will remain on the sidelines of RXRX stock.

Recursion uses a data-driven approach to drug discovery, launching four clinical trials in 2021 and planning a fifth in oncology. Click here to read more.